About
ReAx Biotechnologies is a chemoproteomics drug discovery company that uses a proprietary chemoproteomics platform to identify and develop therapies against challenging protein targets.
Explore ReAx Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.